Filing Details
- Accession Number:
- 0001654954-19-007706
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-27 07:33:16
- Reporting Period:
- 2019-06-26
- Accepted Time:
- 2019-06-27 07:33:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1001316 | Tg Therapeutics Inc. | TGTX | Pharmaceutical Preparations (2834) | 363898269 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1038977 | S Michael Weiss | 2 Gansevoort Street, 9Th Floor New York NY 10014 | Ceo And President | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-06-26 | 50,000 | $7.04 | 12,878,185 | No | 4 | P | Indirect | See Note 3 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Note 3 |
Footnotes
- Mr. Weiss purchased 50,000 shares in the open market at a price of $7.035 per share.
- Included in Mr. Weiss' beneficial ownership are 4,910,010 shares of Common Stock issued to Opus Point Partners, LLC, of which Mr. Weiss is a co-founder, managing partner, and principal and beneficially owns a 50% interest.
- The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member.
Billionaire Hedge Funds
